华西药学杂志
華西藥學雜誌
화서약학잡지
WEST CHINA JOURNAL OF PHARMACEUTICAL SCIENCES
2001年
1期
64-65
,共2页
彭兵%雷文章%吴言涛%刘小菁%强欧
彭兵%雷文章%吳言濤%劉小菁%彊歐
팽병%뢰문장%오언도%류소정%강구
生脉注射液%炎症介质%阻塞性黄疸%肾功能
生脈註射液%炎癥介質%阻塞性黃疸%腎功能
생맥주사액%염증개질%조새성황달%신공능
目的:观察生脉注射液对阻塞性黄疸(阻黄)术后炎症介质及肾功能的作用。方法:阻黄及非黄疸的肝胆外科患者分成三组,术后给予一般治疗阻黄(OJ)组、非黄疸(NON-OJ)组及生脉注射液治疗阻黄组。动态观察血浆炎症介质内毒素(LPs)、肿瘤坏死因子(TNF-α)、白细胞介素-6,8(IL-6,IL-8)、内皮素(ET)以及肾脏功能指标尿转铁蛋白(TFR)、尿白蛋白(ALB)及尿视黄醇(RBP)的变化。结果:生脉注射液治疗组术后7天与术后1天相比,LPs、IL-6、IL-8、ET、TNF-α、TFR、RBP、ALB明显下降(P<0.05〉,且低于或接近术前水平,黄疸对照组在术后7天与术后1天相比无显著差异(P>0.05)。结论:生脉注射液对阻黄患者术后LPs有拮抗作用,同时降低其它炎症介质水平,另外还具有保护肾脏功能的作用。
目的:觀察生脈註射液對阻塞性黃疸(阻黃)術後炎癥介質及腎功能的作用。方法:阻黃及非黃疸的肝膽外科患者分成三組,術後給予一般治療阻黃(OJ)組、非黃疸(NON-OJ)組及生脈註射液治療阻黃組。動態觀察血漿炎癥介質內毒素(LPs)、腫瘤壞死因子(TNF-α)、白細胞介素-6,8(IL-6,IL-8)、內皮素(ET)以及腎髒功能指標尿轉鐵蛋白(TFR)、尿白蛋白(ALB)及尿視黃醇(RBP)的變化。結果:生脈註射液治療組術後7天與術後1天相比,LPs、IL-6、IL-8、ET、TNF-α、TFR、RBP、ALB明顯下降(P<0.05〉,且低于或接近術前水平,黃疸對照組在術後7天與術後1天相比無顯著差異(P>0.05)。結論:生脈註射液對阻黃患者術後LPs有拮抗作用,同時降低其它炎癥介質水平,另外還具有保護腎髒功能的作用。
목적:관찰생맥주사액대조새성황달(조황)술후염증개질급신공능적작용。방법:조황급비황달적간담외과환자분성삼조,술후급여일반치료조황(OJ)조、비황달(NON-OJ)조급생맥주사액치료조황조。동태관찰혈장염증개질내독소(LPs)、종류배사인자(TNF-α)、백세포개소-6,8(IL-6,IL-8)、내피소(ET)이급신장공능지표뇨전철단백(TFR)、뇨백단백(ALB)급뇨시황순(RBP)적변화。결과:생맥주사액치료조술후7천여술후1천상비,LPs、IL-6、IL-8、ET、TNF-α、TFR、RBP、ALB명현하강(P<0.05〉,차저우혹접근술전수평,황달대조조재술후7천여술후1천상비무현저차이(P>0.05)。결론:생맥주사액대조황환자술후LPs유길항작용,동시강저기타염증개질수평,령외환구유보호신장공능적작용。
OBJECTIVE:To investigate the effect of Shengmai injection on inflammatory mediator and renal injury in obstructive jaundice.METHODS:The patients with obstructive jaundice were randomly divided into 2 groups. 15 cases of non-jaundiced patients as another control group according to preoperative arrangement. The plasma ET, LPs, TNF-а, IL-6, IL-8 and urine RBP, TFR, ALB were measured pre and post operative 1, 4, 7 days.RESULTS:LPs , TNF-а, IL-6, IL-8, ET, RBP, TFR and ALB level of Shengmai injection group during post-operative 7 day were obviously lowered as compared with the same group during post-operative 1 day(P<0.05).CONCLUSION:post-operative uses of Shengmai injection might effectively decrease the post-operative level of plasma LPs, ET, TNF-α and IL-6,IL-8. At the mean time, Shengmai injection may protect renal function by inhibiting inflammatory mediator and improving blood dynamics.